{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T08:45:50Z","timestamp":1793090750773,"version":"4.5.0"},"reference-count":140,"publisher":"Informa UK Limited","issue":"6","funder":[{"name":"TBVAC2020","award":["643381-TBVAC2020- H2020-PHC-2014-2015"],"award-info":[{"award-number":["643381-TBVAC2020- H2020-PHC-2014-2015"]}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Anti-infective Therapy"],"published-print":{"date-parts":[[2018,6,3]]},"DOI":"10.1080\/14787210.2018.1483238","type":"journal-article","created":{"date-parts":[[2018,5,31]],"date-time":"2018-05-31T09:02:47Z","timestamp":1527757367000},"page":"501-512","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":72,"title":["Preventive therapy for tuberculosis in rheumatological patients undergoing therapy with biological drugs"],"prefix":"10.1080","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8360-4376","authenticated-orcid":false,"given":"Delia","family":"Goletti","sequence":"first","affiliation":[{"name":",","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Petrone","sequence":"additional","affiliation":[{"name":",","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Ippolito","sequence":"additional","affiliation":[{"name":"Scientific Direction, \u201cL. Spallanzani\u201d National Institute for Infectious Diseases (INMI), IRCCS, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Niccoli","sequence":"additional","affiliation":[{"name":",","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlotta","family":"Nannini","sequence":"additional","affiliation":[{"name":",","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Cantini","sequence":"additional","affiliation":[{"name":",","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2018,6,12]]},"reference":[{"key":"e_1_3_3_3_1","unstructured":"WHO. TB REPORT. [cited 2018 Feb 7]. Available from: http:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/259366\/9789241565516-eng.pdf?sequence=1. (2017)."},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002152"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/1074-7613(95)90001-2"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2016.76"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00070812"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1995.03530020061033"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.21978"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0029563"},{"issue":"7","key":"e_1_3_3_11_1","first-page":"89","article-title":"Mycobacterial infections in solid organ transplant recipients","volume":"20","author":"ESCMID Study Group of Infection in Compromised Hosts","year":"2014","unstructured":"ESCMID Study Group of Infection in Compromised Hosts, Meije Y, Piersimoni C, Torre-cisneros J, et al. Mycobacterial infections in solid organ transplant recipients. Clin Microbiol Infect. 2014;20(Suppl 7):89\u2013101.","journal-title":"Clin Microbiol Infect"},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2006.03.029"},{"key":"e_1_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhin.2005.09.020"},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)60235-9"},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200012010-00016"},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.313.7056.522"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2014.06.019"},{"issue":"4","key":"e_1_3_3_18_1","first-page":"436","article-title":"Incidence of tuberculosis among health care workers at a private university hospital in South Korea","volume":"12","author":"Jo KW","year":"2008","unstructured":"Jo KW, Woo JH, Hong Y, et al. Incidence of tuberculosis among health care workers at a private university hospital in South Korea. Int J Tuberc Lung Dis. 2008;12(4):436\u2013440.","journal-title":"Int J Tuberc Lung Dis"},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.162.5.2004154"},{"issue":"7","key":"e_1_3_3_20_1","first-page":"823","article-title":"Expanding the epidemiologic profile: risk factors for active tuberculosis in people immigrating to Ontario","volume":"163","author":"Wobeser WL","year":"2000","unstructured":"Wobeser WL, Yuan L, Naus M, et al. Expanding the epidemiologic profile: risk factors for active tuberculosis in people immigrating to Ontario. CMAJ. 2000;163(7):823\u2013828.","journal-title":"CMAJ"},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.5588\/ijtld.17.0340"},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.2471\/BLT.13.117267"},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.140099"},{"key":"e_1_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.140097"},{"key":"e_1_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01012-2016"},{"key":"e_1_3_3_26_1","doi-asserted-by":"publisher","DOI":"10.1128\/jb.178.5.1274-1282.1996"},{"key":"e_1_3_3_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)02742-2"},{"key":"e_1_3_3_28_1","article-title":"First evaluation of quantiFERON-TB gold plus performance in contact screening","author":"Barcellini L","year":"2016","unstructured":"Barcellini L, Borroni E, Brown J, et al. First evaluation of quantiFERON-TB gold plus performance in contact screening. Eur Respir J. 2016;47:1587\u20131590.","journal-title":"Eur Respir J"},{"key":"e_1_3_3_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2016.09.008"},{"key":"e_1_3_3_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tube.2017.06.002"},{"key":"e_1_3_3_31_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200402-179OC"},{"key":"e_1_3_3_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2014.06.009"},{"key":"e_1_3_3_33_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1101122"},{"key":"e_1_3_3_34_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu795"},{"key":"e_1_3_3_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(16)30436-2"},{"issue":"12","key":"e_1_3_3_36_1","first-page":"1179","article-title":"Latent mycobacterium tuberculosis infection","volume":"373","author":"Getahun H","year":"2015","unstructured":"Getahun H, Chaisson RE, Raviglione M. Latent mycobacterium tuberculosis infection. N Engl J Med. 2015;373(12):1179\u20131180.","journal-title":"N Engl J Med"},{"key":"e_1_3_3_37_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.21043"},{"issue":"11","key":"e_1_3_3_38_1","first-page":"1311","article-title":"Selected RD1 peptides for active tuberculosis diagnosis: comparison of a gamma interferon whole-blood enzyme-linked immunosorbent assay and an enzyme-linked immunospot assay","volume":"12","author":"Goletti D","year":"2005","unstructured":"Goletti D, Vincenti D, Carrara S, et al. Selected RD1 peptides for active tuberculosis diagnosis: comparison of a gamma interferon whole-blood enzyme-linked immunosorbent assay and an enzyme-linked immunospot assay. Clin Diagn Lab Immunol. 2005;12(11):1311\u20131316.","journal-title":"Clin Diagn Lab Immunol"},{"issue":"3","key":"e_1_3_3_39_1","first-page":"246","article-title":"Comparison of a commercial interferon-gamma release assay and tuberculin skin test for the detection of latent tuberculosis infection in Hong Kong arthritis patients who are candidates for biologic agents","volume":"23","author":"So H","year":"2017","unstructured":"So H, Yuen CS, Yip RM. Comparison of a commercial interferon-gamma release assay and tuberculin skin test for the detection of latent tuberculosis infection in Hong Kong arthritis patients who are candidates for biologic agents. Hong Kong Med J. 2017;23(3):246\u2013250.","journal-title":"Hong Kong Med J"},{"key":"e_1_3_3_40_1","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00028510"},{"key":"e_1_3_3_41_1","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00107608"},{"key":"e_1_3_3_42_1","doi-asserted-by":"publisher","DOI":"10.4081\/idr.2016.6568"},{"key":"e_1_3_3_43_1","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0b013e3283474d62"},{"issue":"1","key":"e_1_3_3_44_1","first-page":"84","article-title":"T-cell assay conversions and reversions among household contacts of tuberculosis patients in rural India","volume":"13","author":"Pai M","year":"2009","unstructured":"Pai M, Joshi R, Dogra S, et al. T-cell assay conversions and reversions among household contacts of tuberculosis patients in rural India. Int J Tuberc Lung Dis. 2009;13(1):84\u201392.","journal-title":"Int J Tuberc Lung Dis"},{"key":"e_1_3_3_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2012.10.017"},{"key":"e_1_3_3_46_1","doi-asserted-by":"publisher","DOI":"10.3109\/09546634.2015.1115815"},{"key":"e_1_3_3_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(11)70210-9"},{"key":"e_1_3_3_48_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201502-0232OC"},{"key":"e_1_3_3_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)01316-1"},{"key":"e_1_3_3_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)32070-0"},{"key":"e_1_3_3_51_1","doi-asserted-by":"publisher","DOI":"10.1038\/gene.2010.51"},{"key":"e_1_3_3_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(16)00048-5"},{"key":"e_1_3_3_53_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-9-182"},{"key":"e_1_3_3_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tube.2017.07.001"},{"key":"e_1_3_3_55_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0183846"},{"key":"e_1_3_3_56_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0018315"},{"key":"e_1_3_3_57_1","doi-asserted-by":"publisher","DOI":"10.1111\/sji.12493"},{"key":"e_1_3_3_58_1","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00140009"},{"key":"e_1_3_3_59_1","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00132-07"},{"key":"e_1_3_3_60_1","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00111-09"},{"key":"e_1_3_3_61_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-016-3436-0"},{"key":"e_1_3_3_62_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-210713"},{"key":"e_1_3_3_63_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kew349"},{"key":"e_1_3_3_64_1","unstructured":"European Medicines Agency. EMA\/CHMP\/589317\/2013 Committee for Medicinal Products for Human Use (CHMP). Procedure No. EMEA\/H\/C\/002576\/0000. Remsima assessment report."},{"key":"e_1_3_3_65_1","unstructured":"European Medicines Agency. EMA\/CHMP\/819219\/2015 Committee for Medicinal Products for Human Use (CHMP). Procedure No. EMEA\/H\/C\/004007\/0000 Benepali assessment report."},{"key":"e_1_3_3_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2015.01.011"},{"key":"e_1_3_3_67_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-012567"},{"key":"e_1_3_3_68_1","doi-asserted-by":"publisher","DOI":"10.5588\/ijtld.15.0283"},{"key":"e_1_3_3_69_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.140103"},{"key":"e_1_3_3_70_1","first-page":"8909834","article-title":"Risk of tuberculosis reactivation in patients with rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis receiving non-anti-TNF-targeted biologics","author":"Cantini F","year":"2017","unstructured":"Cantini F, Nannini C, Niccoli L, et al. Risk of tuberculosis reactivation in patients with rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis receiving non-anti-TNF-targeted biologics. Mediators Inflamm. 2017;2017:8909834.","journal-title":"Mediators Inflamm"},{"key":"e_1_3_3_71_1","article-title":"ESCMID study group for infections in compromised hosts (ESGICH) consensus document on the safety of targeted and biological therapies: an infectious diseases perspective (soluble immune effector molecules [I]: anti-tumour necrosis factor-\u03b1 agents)","author":"Baddley JW","unstructured":"Baddley JW, Cantini F, Goletti D, et al. ESCMID study group for infections in compromised hosts (ESGICH) consensus document on the safety of targeted and biological therapies: an infectious diseases perspective (soluble immune effector molecules [I]: anti-tumour necrosis factor-\u03b1 agents). Clin Microbiol Infect. 2018;24:S10-S20.","journal-title":"Clin Microbiol Infect"},{"key":"e_1_3_3_72_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa011110"},{"key":"e_1_3_3_73_1","doi-asserted-by":"publisher","DOI":"10.1086\/421494"},{"issue":"17","key":"e_1_3_3_74_1","first-page":"1","article-title":"CDC. Guidelines for preventing the transmission of mycobacterium tuberculosis in health-care settings","volume":"54","author":"Jensen PA","year":"2005","unstructured":"Jensen PA, Lambert LA, Iademarco MF, et al. CDC. Guidelines for preventing the transmission of mycobacterium tuberculosis in health-care settings. MMWR Recomm Rep. 2005;54(RR\u201317):1\u2013141.","journal-title":"MMWR Recomm Rep"},{"key":"e_1_3_3_75_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1843.2010.01751.x"},{"issue":"7","key":"e_1_3_3_76_1","first-page":"1436","article-title":"Increased risk of tuberculosis in patients with rheumatoid arthritis","volume":"30","author":"Carmona L","year":"2003","unstructured":"Carmona L, Hernandez-Garcia C, Vadillo C, et al. Increased risk of tuberculosis in patients with rheumatoid arthritis. J Rheumatol. 2003;30(7):1436\u20131439.","journal-title":"J Rheumatol"},{"issue":"4","key":"e_1_3_3_77_1","first-page":"706","article-title":"Incidence of tuberculosis in Korean patients with rheumatoid arthritis (RA): effects of RA itself and of tumor necrosis factor blockers","volume":"34","author":"Seong SS","year":"2007","unstructured":"Seong SS, Choi CB, Woo JH, et al. Incidence of tuberculosis in Korean patients with rheumatoid arthritis (RA): effects of RA itself and of tumor necrosis factor blockers. J Rheumatol. 2007;34(4):706\u2013711.","journal-title":"J Rheumatol"},{"key":"e_1_3_3_78_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.24476"},{"key":"e_1_3_3_79_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.140095"},{"key":"e_1_3_3_80_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.21788"},{"key":"e_1_3_3_81_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-203660"},{"key":"e_1_3_3_82_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kex174"},{"key":"e_1_3_3_83_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-203696"},{"key":"e_1_3_3_84_1","doi-asserted-by":"publisher","DOI":"10.1517\/14712598.2015.1103733"},{"key":"e_1_3_3_85_1","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.201701-055ED"},{"key":"e_1_3_3_86_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.21137"},{"key":"e_1_3_3_87_1","doi-asserted-by":"publisher","DOI":"10.1086\/506935"},{"key":"e_1_3_3_88_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.22768"},{"key":"e_1_3_3_89_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2008.11.002"},{"key":"e_1_3_3_90_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.24632"},{"key":"e_1_3_3_91_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.110373"},{"issue":"4","key":"e_1_3_3_92_1","first-page":"189","article-title":"Patient survival and safety with biologic therapy. Results of the Mexican National Registry Biobadamex 1.0","volume":"8","author":"Ventura-Rios L","year":"2012","unstructured":"Ventura-Rios L, Banuelos-Ramirez D, Hernandez-Quiroz Mdel C, et al. Patient survival and safety with biologic therapy. Results of the Mexican National Registry Biobadamex 1.0. Reumatol Clin. 2012;8(4):189\u2013194.","journal-title":"Reumatol Clin"},{"key":"e_1_3_3_93_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2012.06.008"},{"key":"e_1_3_3_94_1","doi-asserted-by":"publisher","DOI":"10.2147\/BTT.S59574"},{"key":"e_1_3_3_95_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-017-1496-5"},{"key":"e_1_3_3_96_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-016-3462-z"},{"key":"e_1_3_3_97_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-014-2669-0"},{"key":"e_1_3_3_98_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12544"},{"key":"e_1_3_3_99_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-205376"},{"key":"e_1_3_3_100_1","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.02803-15"},{"key":"e_1_3_3_101_1","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2016-209397"},{"key":"e_1_3_3_102_1","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2014.29.8.1090"},{"key":"e_1_3_3_103_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0184178"},{"key":"e_1_3_3_104_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kes365"},{"key":"e_1_3_3_105_1","doi-asserted-by":"publisher","DOI":"10.1038\/cti.2017.34"},{"key":"e_1_3_3_106_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.120688"},{"key":"e_1_3_3_107_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0166301"},{"key":"e_1_3_3_108_1","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2017-000567"},{"key":"e_1_3_3_109_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keu172"},{"key":"e_1_3_3_110_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.21386"},{"key":"e_1_3_3_111_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.11137"},{"key":"e_1_3_3_112_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2009.118935"},{"key":"e_1_3_3_113_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2007.072967"},{"key":"e_1_3_3_114_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.rbr.2017.05.003"},{"key":"e_1_3_3_115_1","doi-asserted-by":"publisher","DOI":"10.3109\/s10165-010-0406-3"},{"issue":"7","key":"e_1_3_3_116_1","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1136\/ard.2005.043158","article-title":"British Society for Rheumatology Biologics Register. Baseline comorbidity levels in biologic and standard DMARD treated patients with rheumatoid arthritis: results from a national patient register","volume":"65","author":"BSRBR Control Centre Consortium","year":"2006","unstructured":"BSRBR Control Centre Consortium, Hyrich K, Symmons D, Watson K, et al. British Society for Rheumatology Biologics Register. Baseline comorbidity levels in biologic and standard DMARD treated patients with rheumatoid arthritis: results from a national patient register. Ann Rheum Dis. 2006;65(7):895\u2013898.","journal-title":"Ann Rheum Dis"},{"key":"e_1_3_3_117_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.20627"},{"key":"e_1_3_3_118_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.21705"},{"key":"e_1_3_3_119_1","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2010.144295"},{"key":"e_1_3_3_120_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0178035"},{"key":"e_1_3_3_121_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2011-200690"},{"key":"e_1_3_3_122_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40249-017-0284-4"},{"key":"e_1_3_3_123_1","first-page":"6","volume-title":"Guidelines on the management of latent tuberculosis infection","author":"WHO","year":"2015","unstructured":"WHO. Guidelines on the management of latent tuberculosis infection. 2015. p. 6\u201310. Available from: http:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/136471\/9789241548908_eng.pdf?sequence=1"},{"key":"e_1_3_3_124_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1104875"},{"issue":"2","key":"e_1_3_3_125_1","first-page":"CD001363","article-title":"Isoniazid for preventing tuberculosis in non-HIV infected persons","volume":"2","author":"Smieja MJ","year":"2000","unstructured":"Smieja MJ, Marchetti CA, Cook DJ, et al. Isoniazid for preventing tuberculosis in non-HIV infected persons. Cochrane Database Syst Rev. 2000;2(2):CD001363.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_3_126_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-149-10-200811180-00003"},{"key":"e_1_3_3_127_1","first-page":"CD008597","article-title":"Antibiotic prophylaxis for preventing post solid organ transplant tuberculosis","author":"Adamu B","year":"2014","unstructured":"Adamu B, Abdu A, Abba AA, et al. Antibiotic prophylaxis for preventing post solid organ transplant tuberculosis. Cochrane Database Syst Rev. 2014;4:CD008597.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_3_128_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.73.1.44"},{"issue":"4","key":"e_1_3_3_129_1","first-page":"555","article-title":"International union against tuberculosis committee on prophylaxis","volume":"60","author":"Efficacy of various durations of isoniazid preventive therapy for tuberculosis: five years of follow-up in the IUAT trial","year":"1982","unstructured":"Efficacy of various durations of isoniazid preventive therapy for tuberculosis: five years of follow-up in the IUAT trial. International union against tuberculosis committee on prophylaxis. Bull World Health Organ. 1982;60(4):555\u2013564.","journal-title":"Bull World Health Organ"},{"key":"e_1_3_3_130_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1986.03370120057023"},{"key":"e_1_3_3_131_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.281.11.1014"},{"key":"e_1_3_3_132_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200303-390OC"},{"key":"e_1_3_3_133_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2016.11.006"},{"issue":"4","key":"e_1_3_3_134_1","first-page":"S221","article-title":"This official statement of the American Thoracic Society was adopted by the ATS board of directors, July 1999. This is a joint statement of the American Thoracic Society (ATS) and the Centers for Disease Control and Prevention (CDC). This statement was endorsed by the Council of the Infectious Diseases Society of America (IDSA), September 1999, and the sections of this statement","volume":"161","author":"Targeted tuberculin testing and treatment of latent tuberculosis infection","year":"2000","unstructured":"Targeted tuberculin testing and treatment of latent tuberculosis infection. This official statement of the American Thoracic Society was adopted by the ATS board of directors, July 1999. This is a joint statement of the American Thoracic Society (ATS) and the Centers for Disease Control and Prevention (CDC). This statement was endorsed by the Council of the Infectious Diseases Society of America (IDSA), September 1999, and the sections of this statement. Am J Respir Crit Care Med. 2000;161(4Pt 2):S221\u201347.","journal-title":"Am J Respir Crit Care Med"},{"key":"e_1_3_3_135_1","doi-asserted-by":"publisher","DOI":"10.7326\/M14-1019"},{"key":"e_1_3_3_136_1","volume-title":"Randomized clinical trial comparing 4RIF vs. 9INH for LTBI treatment-effectiveness","author":"Menzies D","year":"2016","unstructured":"Menzies D. Randomized clinical trial comparing 4RIF vs. 9INH for LTBI treatment-effectiveness. 2016.NCT00931736."},{"key":"e_1_3_3_137_1","doi-asserted-by":"publisher","DOI":"10.1086\/427802"},{"key":"e_1_3_3_138_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-007-0591-4"},{"key":"e_1_3_3_139_1","doi-asserted-by":"publisher","DOI":"10.5152\/eurjrheumatol.2014.019"},{"key":"e_1_3_3_140_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2009.10.012"},{"key":"e_1_3_3_141_1","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmi.2018.02.002","article-title":"ESCMID study group for infections in compromised hosts (ESGICH) consensus document on the safety of targeted and biological therapies: an infectious diseases perspective (soluble immune effector molecules [II]: agents targeting interleukins, immunoglobulins and complement factors)","author":"Winthrop KL","year":"2018","unstructured":"Winthrop KL, Mariette X, Silva JT, et al. ESCMID study group for infections in compromised hosts (ESGICH) consensus document on the safety of targeted and biological therapies: an infectious diseases perspective (soluble immune effector molecules [II]: agents targeting interleukins, immunoglobulins and complement factors). Clin Microbiol Infect. 2018;24:S21\u2013S40.","journal-title":"Clin Microbiol Infect"},{"key":"e_1_3_3_142_1","doi-asserted-by":"publisher","DOI":"10.1111\/resp.13272"}],"container-title":["Expert Review of Anti-infective Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14787210.2018.1483238","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:57:07Z","timestamp":1770944227000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14787210.2018.1483238"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,3]]},"references-count":140,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6,3]]}},"alternative-id":["10.1080\/14787210.2018.1483238"],"URL":"https:\/\/doi.org\/10.1080\/14787210.2018.1483238","relation":{},"ISSN":["1478-7210","1744-8336"],"issn-type":[{"value":"1478-7210","type":"print"},{"value":"1744-8336","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,3]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierz20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierz20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2018-02-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-05-24","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-06-12","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}